Analysis of the new coronavirus (SARS-CoV-2) based on epigenetics
- Funded by RIKEN
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
RIKENPrincipal Investigator
N/A
Research Location
JapanLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
We are analyzing the effects of methyltransferases that cause RNA methylation such as N6-methyladenosine of SARS-CoV-2 RNA on virus replication and host response by machine learning, and exploring the possibilities to use it as a target for COVID-19 therapy.